Cargando…

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups

Universal tumor DNA testing in epithelial ovarian cancer patients can function not only as an efficient prescreen for hereditary cancer testing, but may also guide treatment choices. This innovation, introduced as Tumor-First workflow, offers great opportunities, but ensuring optimal multidisciplina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witjes, Vera M., Braspenning, Jozé C. C., Hoogerbrugge, Nicoline, Smolders, Yvonne H. C. M., Hermkens, Dorien M. A., Mourits, Marian J. E., Ligtenberg, Marjolijn J. L., Ausems, Margreet G. E. M., de Hullu, Joanne A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829642/ https://www.ncbi.nlm.nih.gov/pubmed/35570228 http://dx.doi.org/10.1007/s10689-022-00294-0

Ejemplares similares

Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing
por: Witjes, Vera M., et al.
Publicado: (2021)

Response to Tomao, Panici, and Tomao
por: Vos, Janet R, et al.
Publicado: (2019)

Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome
por: Elze, Lisa, et al.
Publicado: (2023)

Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
por: te Paske, Iris B. A. W., et al.
Publicado: (2020)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

Familial gastric cancer: detection of a hereditary cause helps to understand its etiology
por: Vogelaar, Ingrid P, et al.
Publicado: (2012)

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011)

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation()()()
por: Eissing, Marc, et al.
Publicado: (2018)

Surveillance of women at high risk for hereditary ovarian cancer is inefficient
por: Oei, A L, et al.
Publicado: (2006)

Adequacy of family history taking in ovarian cancer patients: a population-based study
por: van Altena, Anne M., et al.
Publicado: (2012)

Most Patients with Colorectal Tumors at Young Age Do Not Visit a Cancer Genetics Clinic
por: Overbeek, Lucia I. H., et al.
Publicado: (2008)

DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
por: Sie, Aisha S, et al.
Publicado: (2012)

Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome
por: Vos, Janet R., et al.
Publicado: (2020)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
por: Oei, A L M, et al.
Publicado: (2006)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma
por: Boesaard, Ewout P, et al.
Publicado: (2014)

High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling
por: Sie, Aisha S., et al.
Publicado: (2015)

Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016)

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
por: Harmsen, Marline G., et al.
Publicado: (2017)

Improving calculation, interpretation and communication of familial colorectal cancer risk: Protocol for a randomized controlled trial
por: Dekker, Nicky, et al.
Publicado: (2010)

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect
por: Vogelaar, Ingrid P., et al.
Publicado: (2015)

Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients
por: van der Giessen, Jeanine A. M., et al.
Publicado: (2020)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients
por: Bokkers, Kyra, et al.
Publicado: (2023)

Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer
por: Bokkers, Kyra, et al.
Publicado: (2021)

Response to the Letter to the Editor
por: Braspenning, Jozé, et al.
Publicado: (2013)

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
por: Mohammadi, Leila, et al.
Publicado: (2009)

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
por: Gómez García, Encarna B, et al.
Publicado: (2009)

Ribosomal Protein Mutations Result in Constitutive p53 Protein Degradation through Impairment of the AKT Pathway
por: Antunes, Ana T., et al.
Publicado: (2015)

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

Patients’ and professionals’ perspectives on implementation of opportunistic salpingectomy: a mixed-method study
por: Gelderblom, Malou E., et al.
Publicado: (2021)

Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals
por: van der Giessen, Jeanine, et al.
Publicado: (2020)

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study
por: de Jonge, Marthe M, et al.
Publicado: (2021)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013)

NTHL1 defines novel cancer syndrome
por: Kuiper, Roland P., et al.
Publicado: (2015)

Future steps in cardio-oncology—a national multidisciplinary survey among healthcare professionals in the Netherlands
por: Koop, Yvonne, et al.
Publicado: (2022)

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors
por: Stroot, Iris A.S., et al.
Publicado: (2023)

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
por: van der Post, R S, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_t6ri26gfl5ik78372ia9cb1c5k